Earlier this summer, Mary E. Klotman, MD, was appointed to a second five-year term as dean of the School of Medicine. In a wide-ranging interview, she looks back at the successes, challenges, and lessons learned during her eventful first term as dean and shares her thoughts on plans for the next five years.

Edward Patz, MD, James and Alice Chen Distinguished Professor of Radiology at Duke University School of Medicine, was awarded the Joseph W.

A Duke-led international research team has discovered one of the ways that drug resistance can develop: a process by which mobile DNA sequences called transposons trigger “hypermutation,” allowing certain genetic components to multiply unchecked.   

Closely related to smallpox, the monkeypox virus spreads through prolonged skin-to-skin contact. As a national health emergency is declared, three Duke experts discuss testing, community responses and who is at risk.

The Duke University Neuroscience Experience (DUNE) is a summer mentorship program that pairs graduate students and postdoctoral researchers with inquisitive high schoolers, and provides them with hands-on research experience and professional development training five days a week, 9 -5.

With an eye on the future, The Duke Physician Assistant Program (DPAP) recently held a faculty and staff event titled, “DPAP 2027: Disruptive Innovation for the Future of PA Education.”   

The Duke Clinical Research Institute (DCRI) has been named the Clinical Trials Data Coordinating Center for large-scale national research studies aimed at understanding and improving the treatment of long COVID.

Although typically classified as a single ethnic group, people of Hispanic heritage have markedly different risks for brain tumors based on their geographic origins, suggesting greater diversity that warrants attention in the health care setting.

This summer, eight scholars from across the country were paired with a faculty research mentor to learn laboratory skills, designing a research project, and effectively presenting future research.

Murali Doraiswamy, M.B.B.S., sat down with Robert Califf, M.D., commissioner of the Food and Drug Administration (FDA) and the two discussed a range of issues, focusing on potential opportunities to enhance psychiatric care and support patients.